Supply Chain

The U.S. government shifted control of the strategic national stockpile back to HHS after  giving control to the Federal Emergency Management Agency in March, The Washington Post reported. 

Since the FDA said in late May that it found unacceptable levels of a caricinogen in metformin — the generic name for a drug commonly used to control blood pressure in Type 2 diabetes patients — five drugmakers have issued…

ASCs across the U.S. are figuring out how to approach COVID-19 testing of patients and staff at their centers.

Twenty-eight generic drugs in 405 dosages made their first appearance on the FDA's shortage list this year, according to a USA Today analysis.

Amid a lack of federal regulation of lab charges, a diagnostic lab in Texas has charged insurers as much as $2,315 for the same COVID-19 test that costs $100 elsewhere, The New York Times reported. 

CMS approved transitional pass-through status for Anjeso, a once-daily intravenous analgesic intended for the management of moderate to severe pain in adults.

Medline became the exclusive supply distributor for Yuma (Ariz.) Regional Medical Center through a $12 million agreement.

With only one modestly effective COVID-19 treatment known, the world is scrambling to develop better therapies. Luckily, there are five strong contenders, as reported by NPR. 

Smith+Nephew launched its Intellio Connected Tower Solution to improve operating room efficiencies in ASCs and hospitals, according to a June 11 announcement.

The COVID-19 pandemic is forcing vendors such as Brasseler USA Surgical Instrumentation to rethink their handling of surgery center visits.